Global Drug Retail

Summary

Datamonitor's Global Drug Retail industry profile is an essential resource for top-level data and analysis covering the drug retail industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information.

Scope

• Contains an executive summary and data on value, volume and/or segmentation
• Provides textual analysis of the industry's recent performance and future prospects
• Incorporates in-depth five forces competitive environment analysis and scorecards
• Includes a five-year forecast of the industry
• The leading companies are profiled with supporting key financial metrics
• Supported by the key macroeconomic and demographic data affecting the market

Highlights

• Detailed information is included on market size, measured by value and/or volume
• Five forces scorecards provide an accessible yet in depth view of the market's competitive landscape
• Market shares are covered by manufacturer or brand

Why you should buy this report

• Spot future trends and developments
• Inform your business decisions
• Add weight to presentations and marketing materials
• Save time carrying out entry-level research

Market Definition

• The drug retail sector consists of the total revenues generated through the sales of all prescription drugs and over the counter medicines via outlets for which drug retail is the primary revenue source. The sector is valued at retail selling price with any currency conversions calculated using constant 2007 annual average exchange rates.
• For the purpose of this report the Americas comprise Brazil, Canada, Mexico and the US.
• Europe comprises Belgium, the Czech Republic, Denmark, France, Germany, Hungary, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden and the UK.
• Asia-Pacific comprises Australia, China, Japan, India, Singapore, South Korea and Taiwan.
• The global figure comprises the Americas, Asia-Pacific and Europe.

Content